Carl Shaia

1.8k total citations
49 papers, 862 citations indexed

About

Carl Shaia is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Carl Shaia has authored 49 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 13 papers in Epidemiology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Carl Shaia's work include Viral Infections and Outbreaks Research (20 papers), Viral Infections and Vectors (20 papers) and SARS-CoV-2 and COVID-19 Research (17 papers). Carl Shaia is often cited by papers focused on Viral Infections and Outbreaks Research (20 papers), Viral Infections and Vectors (20 papers) and SARS-CoV-2 and COVID-19 Research (17 papers). Carl Shaia collaborates with scholars based in United States, United Kingdom and Netherlands. Carl Shaia's co-authors include Vincent J. Munster, Todd M. Bell, Eric R. Wilkinson, Kathleen A. Cashman, Heinz Feldmann, Emmie de Wit, Julia R. Port, Jonathan E. Schulz, Myndi G. Holbrook and Claude Kwe Yinda and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Carl Shaia

48 papers receiving 854 citations

Peers

Carl Shaia
Brandi N. Williamson United States
Shamus P. Keeler United States
Shelley P. Honnold United States
Wun‐Ju Shieh United States
Julia R. Port United States
Rodrigo I. Santos United States
Catherine V. Badger United States
Janice M. Rusnak United States
Linda Easterbrook United Kingdom
Brandi N. Williamson United States
Carl Shaia
Citations per year, relative to Carl Shaia Carl Shaia (= 1×) peers Brandi N. Williamson

Countries citing papers authored by Carl Shaia

Since Specialization
Citations

This map shows the geographic impact of Carl Shaia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Shaia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Shaia more than expected).

Fields of papers citing papers by Carl Shaia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Shaia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Shaia. The network helps show where Carl Shaia may publish in the future.

Co-authorship network of co-authors of Carl Shaia

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Shaia. A scholar is included among the top collaborators of Carl Shaia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Shaia. Carl Shaia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hawman, David W., Shanna Leventhal, Kimberly Meade‐White, et al.. (2025). A replicating RNA vaccine confers protection against Crimean-Congo hemorrhagic fever in cynomolgus macaques. EBioMedicine. 115. 105698–105698. 1 indexed citations
2.
Leventhal, Shanna, Dean Clift, Kimberly Meade‐White, et al.. (2024). Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21. Nature Communications. 15(1). 9236–9236. 6 indexed citations
3.
Hawman, David W., Shanna Leventhal, Kimberly Meade‐White, et al.. (2024). A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever. npj Vaccines. 9(1). 86–86. 11 indexed citations
4.
Port, Julia R., Dylan H. Morris, Claude Kwe Yinda, et al.. (2024). Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster. eLife. 12. 1 indexed citations
6.
Tipih, Thomas, Kimberly Meade‐White, Trenton Bushmaker, et al.. (2023). Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection. Antiviral Research. 218. 105703–105703. 12 indexed citations
7.
Port, Julia R., Dylan H. Morris, Claude Kwe Yinda, et al.. (2023). Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster. eLife. 12. 11 indexed citations
8.
Port, Julia R., Claude Kwe Yinda, Victoria A. Avanzato, et al.. (2023). Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters. Nature Communications. 14(1). 6592–6592. 7 indexed citations
9.
Clancy, Chad S., Kimberly Meade‐White, Carl Shaia, et al.. (2023). Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster. Veterinary Sciences. 10(9). 536–536. 1 indexed citations
10.
Zeng, Xiankun, Todd M. Bell, Carl Shaia, et al.. (2023). Temporal changes in pathology and viral RNA distribution in guinea pigs following separate infection with two New World Arenaviruses. PLoS neglected tropical diseases. 17(9). e0011620–e0011620. 1 indexed citations
11.
Haddock, Elaine, Julie Callison, Stephanie N. Seifert, et al.. (2022). Three-Week Old Pigs Are Not Susceptible to Productive Infection with SARS-COV-2. Microorganisms. 10(2). 407–407. 4 indexed citations
12.
Rosenke, Kyle, Friederike Feldmann, Eric Bohrnsen, et al.. (2022). Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques. JCI Insight. 8(4). 24 indexed citations
13.
Cockrell, Diane C., et al.. (2022). Characterization of Coxiella burnetii Dugway Strain Host-Pathogen Interactions In Vivo. Microorganisms. 10(11). 2261–2261. 2 indexed citations
14.
Rosenke, Kyle, Atsushi Okumura, Matthew Lewis, et al.. (2022). Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model. JCI Insight. 7(13). 25 indexed citations
15.
Speranza, Emily, Brandi N. Williamson, Friederike Feldmann, et al.. (2021). Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Science Translational Medicine. 13(578). 100 indexed citations
16.
Port, Julia R., Danielle R. Adney, Benjamin Schwarz, et al.. (2021). High-Fat High-Sugar Diet-Induced Changes in the Lipid Metabolism Are Associated with Mildly Increased COVID-19 Severity and Delayed Recovery in the Syrian Hamster. Viruses. 13(12). 2506–2506. 21 indexed citations
17.
Yinda, Claude Kwe, Julia R. Port, Trenton Bushmaker, et al.. (2021). K18-hACE2 mice develop respiratory disease resembling severe COVID-19. PLoS Pathogens. 17(1). e1009195–e1009195. 165 indexed citations
18.
Long, Carrie M., Paul A. Beare, Diane C. Cockrell, et al.. (2021). Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity. npj Vaccines. 6(1). 38–38. 25 indexed citations
19.
Downs, Isaac, Carl Shaia, Xiankun Zeng, et al.. (2020). Natural History of Aerosol Induced Lassa Fever in Non-Human Primates. Viruses. 12(6). 593–593. 11 indexed citations
20.
Bell, Todd M., Carl Shaia, Jeremy J. Bearss, et al.. (2016). Temporal Progression of Lesions in Guinea Pigs Infected With Lassa Virus. Veterinary Pathology. 54(3). 549–562. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026